CTKB Stock Price Prediction 2026
Cytek Biosciences, Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- Moving averages converging - equilibrium state
- MACD converging near zero line - potential energy building
- Volume showing distribution (CMF: -0.1455)
- Price near support at $4.87
Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.
Volume Trend: Distribution
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $5.08 | +1.6% |
| 90 Days | $5.25 | +5.0% |
| 6 Months | $5.50 | +10.0% |
| 1 Year | $6.00 | +20.0% |
More CTKB Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results